SCHEMBL4096583

SCHEMBL4096583

C=CP(=O)(CCC(=O)OCC)OCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
TRPA1 O75762 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CYP1A2 P05177 1/20 0.39
POLB P06746 1/20 0.38
MGAM O43451 1/20 0.38
GAA P10253 1/20 0.38
SI P14410 1/20 0.38
MGAM2 Q2M2H8 1/20 0.38
ALOX15 P16050 2/20 0.37
NR1I2 O75469 1/20 0.36
PGR P06401 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
PTGS2 P35354 1/20 0.36
PDE4D Q08499 1/20 0.36
PKM P14618 1/20 0.35
TSHR P16473 2/20 0.34
CYP3A4 P08684 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17072464 0.89 SMN1; SMN2 (0.35) ALDH1A1TRPA1SMN1; SMN2CYP1A2POLB
SCHEMBL15743397 0.89 SMN1; SMN2 (0.35) ALDH1A1TRPA1SMN1; SMN2CYP1A2POLB
SCHEMBL8232933 0.89 CYP1A2 (0.43) ALDH1A1TRPA1CYP1A2GAAALOX15
SCHEMBL28644708 0.77 SMN1; SMN2 (0.38) ALDH1A1TRPA1SMN1; SMN2CYP1A2POLB
SCHEMBL710885 0.76 PPARD (0.54) ALDH1A1TRPA1SMN1; SMN2CYP1A2POLB
SCHEMBL11025207 0.74 CYP1A2 (0.44) ALDH1A1TRPA1SMN1; SMN2CYP1A2POLB
SCHEMBL7716763 0.74 PPARD (0.55) ALDH1A1TRPA1SMN1; SMN2CYP1A2POLB
SCHEMBL11806061 0.73 GAA (0.50) ALDH1A1TRPA1SMN1; SMN2CYP1A2POLB
SCHEMBL2354099 0.73 CYP1A2 (0.42) ALDH1A1TRPA1SMN1; SMN2CYP1A2POLB
SCHEMBL8231853 0.72 ALDH1A1 (0.44) ALDH1A1TRPA1SMN1; SMN2CYP1A2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3122757-B1 CHARGED LINKERS AND THEIR USES FOR CONJUGATION HANGZHOU DAC BIOTECH CO LTD (CN) 2023-09-06 EP disclosed
US-10696700-B2 Charged linkers and their uses for conjugation HANGZHOU DAC BIOTECH CO., LTD. (CN) 2020-06-30 US disclosed
US-10696699-B2 Charged linkers and their uses for conjugation HANGZHOU DAC BIOTECH CO., LTD. (CN) 2020-06-30 US disclosed
US-10683314-B2 Charged linkers and their uses for conjugation HANGZHOU DAC BIOTECH CO., LTD. (CN) 2020-06-16 US disclosed
US-20190127401-A1 CHARGED LINKERS AND THEIR USES FOR CONJUGATION HANGZHOU DAC BIOTECH CO., LTD. (CN) 2019-05-02 US disclosed
US-20190127399-A1 CHARGED LINKERS AND THEIR USES FOR CONJUGATION HANGZHOU DAC BIOTECH CO., LTD. (CN) 2019-05-02 US disclosed
US-20190127400-A1 CHARGED LINKERS AND THEIR USES FOR CONJUGATION HANGZHOU DAC BIOTECH CO., LTD. (CN) 2019-05-02 US disclosed
US-10131682-B2 Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules HANGZHOU DAC BIOTECH CO., LTD. (CN) 2018-11-20 US disclosed
EP-2922818-B1 HYDROPHILIC LINKERS AND THEIR USES FOR CONJUGATION OF DRUGS TO CELL BINDING MOLECULES HANGZHOU DAC BIOTECH CO LTD (CN) 2018-09-05 EP disclosed
US-20170152274-A1 CHARGED LINKERS AND THEIR USES FOR CONJUGATION HANGZHOU DAC BIOTECH CO., LTD. (CN) 2017-06-01 US disclosed
US-20150250896-A1 HYDROPHILIC LINKERS AND THEIR USES FOR CONJUGATION OF DRUGS TO A CELL BINDING MOLECULES HANGZHOU DAC BIOTECH CO., LTD. (CN) 2015-09-10 US disclosed
US-20150250896-A1 HYDROPHILIC LINKERS AND THEIR USES FOR CONJUGATION OF DRUGS TO A CELL BINDING MOLECULES HANGZHOU DAC BIOTECH CO., LTD. (CN) 2015-09-10 US disclosed
US-20150250896-A1 HYDROPHILIC LINKERS AND THEIR USES FOR CONJUGATION OF DRUGS TO A CELL BINDING MOLECULES HANGZHOU DAC BIOTECH CO., LTD. (CN) 2015-09-10 US disclosed
WO-2014080251-A1 HYDROPHILIC LINKERS AND THEIR USES FOR CONJUGATION OF DRUGS TO CELL BINDING MOLECULES HANGZHOU DAC BIOTECH CO., LTD. (CN) 2014-05-30 WO disclosed
US-20090170813-A1 Hypophosphorous Acid Derivatives and their Therapeutical Applications CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) 2009-07-02 US disclosed
US-20090170813-A1 Hypophosphorous Acid Derivatives and their Therapeutical Applications CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) 2009-07-02 US disclosed
US-20090170813-A1 Hypophosphorous Acid Derivatives and their Therapeutical Applications CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) 2009-07-02 US disclosed
EP-1937699-A2 HYPOPHOSPHOROUS ACID DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2008-07-02 EP disclosed
WO-2007052169-A2 HYPOPHOSPHOROUS ACID DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2007-05-10 WO disclosed
WO-2007052169-A2 HYPOPHOSPHOROUS ACID DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2007-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170152274-A1 CHARGED LINKERS AND THEIR USES FOR CONJUGATION PHOSPHO1, PCTP, CD2BP2 ALDH1A1 4122/4885TRPA1 4872/4885SMN1; SMN2 3710/4885
US-20190127399-A1 CHARGED LINKERS AND THEIR USES FOR CONJUGATION PHOSPHO1, PCTP, CD2BP2 ALDH1A1 4122/4885TRPA1 4872/4885SMN1; SMN2 3710/4885
US-10131682-B2 Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules CD44, EPCAM, ABCG2 ALDH1A1 1784/4885TRPA1 4847/4885SMN1; SMN2 4201/4885
US-10696700-B2 Charged linkers and their uses for conjugation PHOSPHO1, PCTP, CD2BP2 ALDH1A1 4122/4885TRPA1 4872/4885SMN1; SMN2 3710/4885
US-20150250896-A1 HYDROPHILIC LINKERS AND THEIR USES FOR CONJUGATION OF DRUGS TO A CELL BINDING MOLECULES CD44, EPCAM, ABCG2 ALDH1A1 1784/4885TRPA1 4847/4885SMN1; SMN2 4201/4885
US-20090170813-A1 Hypophosphorous Acid Derivatives and their Therapeutical Applications P4HA1, CYP2R1, EGLN3 ALDH1A1 2089/4885TRPA1 4625/4885SMN1; SMN2 2459/4885
US-20190127401-A1 CHARGED LINKERS AND THEIR USES FOR CONJUGATION PHOSPHO1, PCTP, CD2BP2 ALDH1A1 4122/4885TRPA1 4872/4885SMN1; SMN2 3710/4885
US-20190127400-A1 CHARGED LINKERS AND THEIR USES FOR CONJUGATION PHOSPHO1, PCTP, CD2BP2 ALDH1A1 4122/4885TRPA1 4872/4885SMN1; SMN2 3710/4885
US-10683314-B2 Charged linkers and their uses for conjugation PHOSPHO1, PCTP, CD2BP2 ALDH1A1 4122/4885TRPA1 4872/4885SMN1; SMN2 3710/4885
US-10696699-B2 Charged linkers and their uses for conjugation PHOSPHO1, PCTP, CD2BP2 ALDH1A1 4122/4885TRPA1 4872/4885SMN1; SMN2 3710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.